Page 156 - Multidisipliner Covid 19
P. 156

BÖLÜM  09






          4. Cheng P, Zhu H, Witteles RM, et al. Cardiovascular Risks in Patients
             with COVID-19: Potential Mechanisms and Areas of Uncertainty. Curr
             Cardiol Rep. 2020;22(5):1-6. doi:10.1007/s11886-020-01293-2
          5.  Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular
             Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med.
             Published online 2020:1-8. doi:10.1056/nejmoa2007621
          6. ACC’s COVID-19 Hub - American College of Cardiology. Accessed
             June 24, 2020. https://www.acc.org/latest-in-cardiology/features/accs-
             coronavirus-disease-2019-covid-19-hub#sort=%40fcommonsortdate
             90022 descending
          7. European Society of cardiology. ESC Guidance for the Diagnosis and
             Management of CV Disease during the COVID-19 Pandemic. Published
             online 2020:1-115.
          8.  Aktoz M, Altay H, Aslanger E, et al. Türk Kardiyoloji Derneği Uzlaşı
             Raporu: COVID-19 Pandemisi ve Kardiyovasküler Hastalıklar Konu-
             sunda Bilinmesi Gerekenler (25 Mart 2020). Turk Kardiyol Dern Ars.
             2020;48:1-3. doi:10.5543/tkda.2020.97198
          9. Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147,
             CD26 and Other SARS_CoV_2 Associated Molecules in Tissues and
             Immune Cells in Health and in Asthma, COPD, Obesity, Hypertension,
             and COVID_19 Risk Factors.; 2020. doi:10.1111/all.14429
          10.  Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality
             of adult inpatients with COVID-19 in Wuhan, China: a retrospective
             cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-
             6736(20)30566-3
          11.  Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal
             Outcomes of Patients with Coronavirus Disease 2019 (COVID-19).
             JAMA Cardiol. 2020;2019. doi:10.1001/jamacardio.2020.1017
          12.  Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and
             Proposed Management of the Acute COVID-19 Cardiovascular Syn-
             drome. Circulation. 2020;141(23):1903-1914. doi:10.1161/CIRCULA-
             TIONAHA.120.047349
          13.  Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as
             a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respira-
             tory infection. Eur Heart J. 2020;41(19):1861-1862. doi:10.1093/eur-
             heartj/ehaa286
          14.  Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of




                                                                        155
   151   152   153   154   155   156   157   158   159   160   161